Suchergebnisse - "Lane, Joseph M"

PubPharm (364)

1

Osteoporosis and cement usage in total hip arthroplasty

enthalten in: European journal of orthopaedic surgery & traumatology : orthopedie traumatologie | 2024

von Wang, Z. | Wishman, M. | Tutaworn, T. | +3

2

The Effect of Social Isolation on 1-Year Outcomes After Surgical Repair of Low-Energy Hip Fracture

enthalten in: Journal of orthopaedic trauma | 2024

von Mandl, L. | Rajan, M. | Lipschultz, R. | +5

3

Osteoporosis and cement usage in total hip arthroplasty

enthalten in: European journal of orthopaedic surgery & traumatology | 2024

von Wang, Z. | Wishman, M. | Tutaworn, T. | +3

4

What's New in Osteoporosis and Fragility Fractures

enthalten in: The Journal of bone and joint surgery. American volume | 2023

von Lane, J. | Witayakom, W.

CommentOn: J Bone Joint Surg Am. 2022 Sep 7;104(17):1509-1515. - PMID 35880771

5

A clinical prediction model for 10-year risk of self-reported osteoporosis diagnosis in pre- and perimenopausal women

enthalten in: Archives of osteoporosis | 2023

von Zeitlin, J. | Parides, M. | Lane, J. | +2

6

A clinical prediction model for 10-year risk of self-reported osteoporosis diagnosis in pre- and perimenopausal women

enthalten in: Archives of osteoporosis | 2023

von Zeitlin, J. | Parides, M. | Lane, J. | +2

7

Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate : a retrospective study

enthalten in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2023

von Tutaworn, T. | Nieves, J. | Wang, Z. | +3

8

Chronic Warfarin Anticoagulation in Hip Fracture Patients Delays Surgery and Is Associated With Increased Risk of Postoperative Complications : A Multicenter Propensity-Score-Matched Analysis

enthalten in: Journal of orthopaedic trauma | 2023

von Levack, A. | Moore, H. | Stephan, S. | +8

9

Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study

enthalten in: Osteoporosis international | 2023

von Tutaworn, T. | Nieves, J. | Wang, Z. | +3

10

Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study

enthalten in: Osteoporosis international | 2023

von Tutaworn, T. | Nieves, J. | Wang, Z. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[37]